COVID Advisor

PART 1 - As a now renowned (infamous?) U.S pulmonary & critical care specialist with numerous co-authored publications and extensive experience treating COVID-19 in all it’s phases, almost every day of this pandemic, and sometimes multiple times a day, I am contacted by someone in my ever-widening circle of friends, family, or colleagues asking me to help a loved one who is deteriorating from COVID in the hospital. The case is invariably one of an often older (but not always) patient mired on a hospital ward or in an ICU, whose illness has progressed to the point where they require near maximal or maximal oxygen/ventilator settings and the patients and family members begin to question whether “enough is being done” or “is there more the doctors should be doing?” So they reach out.. desperate for help. The therapeutic regimen that their loved one is on is nearly identical in almost all cases, especially on the hospital wards where a generally anemic dose of a corticosteroid called

Dr. Pierre Kory is one of the leaders in the movement to provide early treatment for COVID infection. Kory is a critical care physician (ICU specialist), triple board certified in internal medicine, critical care and pulmonary medicine, and is part of the Frontline COVID-19 Critical Care Alliance (FLCCC), which was among the first to publish COVID treatment guidance. McCullough et al. Reviews in Cardiovascular Medicine, 2020 Dr Pierre Kory spent most of his career at the Beth Israel Medical Center in Manhattan, New York, where he helped run the intensive care unit. He also had a busy outpatient practice. About six years ago, he was recruited to the St. Luke’s Aurora Medical Center in Milwaukee, Wisconsin, where he led the critical care service. “When COVID hit, I was in a leadership position,” he says. “I resigned, because of the way they were handling the pandemic.” Treatment Options Have Been Vehemently Opposed St. Luke’s, like most hospitals across th

New York pulmonologist Dr. Pierre Kory, an unapologetic champion of evidence-based medicine, has had remarkable success treating patients with ivermectin and other therapies during the pandemic. His efforts to get the word out on this treatment protocol as part of the Front Line COVID-19 Critical Care Working Group (FLCCC) have largely been stifled by censorship, ridicule and colleagues — brainwashed by the official narrative. McCullough et al. Reviews in Cardiovascular Medicine, 2020 Kory spoke with Dr. Chris Martenson, host of the Peak Prosperity podcast, about his incredible experiences over the last nearly two years. 1  On December 8, 2020, Kory testified to the Senate Committee on Homeland Security and Governmental Affairs, which held a hearing on “Early Outpatient Treatment: An Essential Part of a COVID-19 Solution.” He called on the NIH, CDC and FDA to review the expansive data on ivermectin to prevent COVID-19, keep t